Pseudotumor Cerebri Market Size Estimation, Business Overview, Growth Outlook, COVID-19 Impact and Share Value By 2023

Pseudotumor Cerebri Market Size, Growth and Share Analysis By Diagnosis (Fundoscopy, Neuroimaging, And Lumbar Puncture), By Treatment (Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication), By The End User – Global Forecast Till 2023

Pseudotumor Cerebri Market Overview

Pseudotumor cerebri is a syndrome of elevated intracranial pressure and mainly occurs in obese women of child-bearing age. It is also known as idiopathic intracranial hypertension. It can cause headaches and vision impairment due to buildup of pressure in the intracranial space. Papilledema is a common complication in cases of pseudotumor cerebri and is the cause of the vision impairment associated with the disease.

The growing prevalence of obesity is the major driver for the global pseudotumor cerebri market. Obesity is a lifestyle condition caused by factors such as diet and lack of physical activity. It comprises of a buildup of adipose tissue in the body, especially in and around the abdomen. The buildup of adipose tissue can put pressure on veins and arteries, causing several conditions, including heart disease and diabetes. Obesity can also cause an increase in intracranial pressure, leading to conditions such as pseudotumor cerebri. The rising technological advancement in medical devices, allowing for more precise and refined treatment of pseudotumor cerebri, is also a major driver for the global pseudotumor cerebri market.

Request Free Sample Copy of the report “Pseudotumor Cerebri Market Research Report – Forecast to 2023” at: https://www.marketresearchfuture.com/sample_request/5709

The global pseudotumor cerebri market size is expected to rise at a strong 6% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global pseudotumor cerebri market is mainly driven by the growing awareness about the condition and the growing prevalence of obesity around the world. The report provides a detailed overview of the global pseudotumor cerebri market’s major drivers and restraints in order to provide to readers a detailed understanding of what is making the market tick.

Major players operating in the global pseudotumor cerebri market are also profiled in the report in order to provide readers with a detailed overview of the market’s competitive landscape. The granular structure and composition of the global pseudotumor cerebri market is also assessed in the report to provide readers with a complete overview of the internal structure and dynamics of the global pseudotumor cerebri market.

Pseudotumor Cerebri Market Regional Analysis:

The Americas dominate the global pseudotumor cerebri market due to the growing prevalence of obesity in the region. Due to the easy availability of cheap junk food in the region, especially in North America, obesity has become a major concern in North American countries such as the U.S. This is likely to remain a major driver for the pseudotumor cerebri market over the forecast period. The increasing prevalence of pseudotumor cerebri in younger patients in North America is also a major driver for the global pseudotumor cerebri market.

Europe is the second largest regional market for pseudotumor cerebri, followed by Asia Pacific. Growing government support towards developments in medical devices as well as technology is likely to be the major driver for the pseudotumor cerebri market in Europe and Asia Pacific.

Pseudotumor Cerebri Market Competitive Leaderboard:

Leading players in the global pseudotumor cerebri market include Zydus Pharmaceutical Inc., West-Ward Pharmaceutical, Teva Pharmaceutical Industries Ltd., Taro Pharmaceutical Industries Ltd., Sophysa, SGPharma Pvt. Ltd., Sanofi, Phoenix Biomedical Corp., Novast Holdings Ltd., Nostrum Laboratories Inc., MercuryPharma, Medtronic, Magstim, Lannett Company Inc., Johnson & Johnson Services Inc., Integra LifeSciences Corporation, Ingenus Pharmaceuticals, Heritage Pharmaceuticals Inc., Elekta AB, Beckersmith Medical Inc., B. Braun Melsungen AG, and Avkare Inc.

Pseudotumor Cerebri Market Segmentation:

The global pseudotumor cerebri market is segmented by diagnosis, treatment, and end user.

By the diagnosis, the pseudotumor cerebri market is classified as fundoscopy, neuroimaging, lumbar puncture, and others.

By the treatment, the pseudotumor cerebri market is classified as surgery, medication, and others. The surgery segment is further segmented into the spinal fluid shunt, optic nerve sheath fenestration (ONSF), dural venous sinus stenting, and bariatric surgery. The medication segment is further segmented into acetazolamide, topiramate, furosemide, steroids, others.

On the basis of the end user, the pseudotumor cerebri market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others. The hospitals segment holds the largest share in the global pseudotumor cerebri market.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/pseudotumor-cerebri-market-5709

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com